NAGE - Niagen Bioscience Inc
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$10.50
DETAILS
HIGH:
$11.00
LOW:
$10.00
MEDIAN:
$10.50
CONSENSUS:
$10.50
UPSIDE:
227.10%
About Niagen Bioscience Inc (https://www.niagenbioscience.com)
Niagen Bioscience Inc operates as a biotechnology enterprise with a core focus on promoting healthy aging. This company is also renowned for its pioneering research into nicotinamide adenine dinucleotide.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Robert N. Fried | Chief Executive Officer & Director | 1960 | $1,212,064 USD |
| Ozan Pamir | Chief Financial Officer & Principal Accounting Officer | 1992 | $648,236 USD |
| Carlos Lopez | Senior Vice President & General Counsel | 1981 | $480,029 USD |
| James Lee | Controller | 1976 | $286,491 USD |
| Frank Louis Jaksch Jr. | Co-Founder & Chairman | 1968 | $70,000 USD |
| Andrew Shao | Senior Vice President of Global Regulatory & Scientific Affairs | – | – |
| Chu Yan | Managing Director of Asia Pacific | – | – |
| Kendall Knysch | Head of Media Relations & Partnerships | – | – |
| Michiko Kelley | Chief Marketing Officer | – | – |
| Wesley Yu | Vice President of Finance | – | – |